Lv31
350 积分 2023-11-15 加入
Targeting the IL-23 Pathway in Inflammatory Bowel Disease
1小时前
已完结
Recent progress on tyrosine kinase 2 JH2 inhibitors
6天前
已完结
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
13天前
已完结
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
13天前
已完结
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds
13天前
已完结
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis
18天前
已完结
PCSK9 and carbohydrate metabolism: A double-edged sword
18天前
已完结
Relocalizing transcriptional kinases to activate apoptosis
19天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
19天前
已完结
HCV RdRp, sofosbuvir and beyond
2个月前
已完结
皖公网安备34019202002308
